Table of Contents
Use this report to:
- Receive an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments.
- Identify the markets in general segments: Vaccines/Therapeutics and Diagnostics.
- Analyze the patents issued for influenza technology by patent number and by issue year.
- The global influenza market reached $5.1 billion in 2015. This market is expected to increase from $5.4 billion in 2016 to $6.4 billion in 2021 at a compound annual growth rate (CAGR) of 3.6% for 2016-2021.
- Vaccines market is expected to grow from $3.9 billion in 2016 to nearly $4.8 billion at a CAGR of 3.9% from 2016 through 2021.
- Diagnostics market is expected to grow from $485 million in 2016 to $635 million in 2021 at a CAGR of 5.5% from 2016 through 2021.
Introduction & Scope
STUDY GOALS AND OBJECTIVES
This BCC Research report, The Global Influenza Market: Vaccines, Therapeutics, and Diagnostics, is an update to the latest edition of the BCC Research report published in 2013. This report provides an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments. The study includes information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers. There is a special emphasis on U.S. and European markets.
REASONS FOR DOING THE STUDY
Annually, up to a half-million people die of influenza and, with the threat of a pandemic in any given year, government agencies and disease prevention organizations are devoted to gaining control of the situation. The 2009 pandemic generated attention to surveillance measures, pandemic preparedness, vaccine production and antiviral control. It also revealed issues with laboratory capacity and the benefits of rapid testing in a pandemic situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. The next five years will continue to display support and funding for many research and development (R&D) programs, product development, and pandemic prevention and/or control by worldwide governments, organizations, and health professionals.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. and European data. The report identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.
The information for this BCC report was obtained through primary and secondary data collection methods. Primary methods included interviews with key representatives in the industry: product development managers, clinical specialists, government departments and other key representatives involved in the influenza industry. Secondary methods included published literature, investment reports, company literature and various business journals that have emphasis on influenza products, technology and related information.
Market data for this report pertains to the worldwide market, with specific U.S. data included. All information is displayed using U.S. dollars at the manufacturers’ level. The base year of the report is 2016, with historical data provided for the years 2010 through 2015, and forecast data provided for 2021. Historical, base year and forecast data are provided for each market segment of the report. Compound annual growth rates are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in R&D, current product growth, and government intervention and stockpiling trends. Competitor market share estimates are provided for each market segment for the years 2013, 2014 and 2015 and the 2016 base year.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented ...
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Summary Influenza, often referred to ...
Note*: This report requires 5 business days to complete. DelveInsight’s H1N1 (Swine Influenza) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...